Results 251 to 260 of about 475,202 (310)

Denosumab Offers Relatively Lower Initial Protection Against Osteoporotic Vertebral Fractures in Treatment‐Naive Patients Compared With Zoledronate

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
We compared the initial efficacy of denosumab (Dmab) and zoledronate (ZOL) in treatment‐naive patients with osteoporosis. This cohort study, based on TriNetX data, evaluated the risks of fractures and mortality using Kaplan–Meier survival analyses, with hazard ratios (HRs) and 95% confidence intervals (CIs).
Ko‐Hsiu Lu   +2 more
wiley   +1 more source

O36 HPV vaccination and cervical screening in SLE patients

open access: yesLupus Science and Medicine
Myles Lewis   +9 more
doaj   +1 more source

Clinical and Biochemical Factors Associated with Delayed Renal Response in Proliferative Lupus Nephritis: A 20-Year Single-Center Multiethnic Cohort Study. [PDF]

open access: yesBiomedicines
Mohd R   +8 more
europepmc   +1 more source

Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study. [PDF]

open access: yesRMD Open
Nikoloudaki M   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy